Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Food and Drug Administration 21 CFR Parts 510 and 520
 AGENCY: Food and Drug Administration, HHS.
 ACTION: Final rule.
 SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for three new animal drug applications (NADAs) from Sweetlix LLC to Ridley U.S. Holdings, Inc.
 DATES: This rule is effective October 28, 2004.
 FOR FURTHER INFORMATION CONTACT: David R. Newkirk, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301-827-6967, e-mail: 
                        *david.newkirk@fda.gov*.


SUPPLEMENTARY INFORMATION: Sweetlix LLC, 175 South Main St., suite 150, Salt Lake City, UT 84111, has informed FDA that it has transferred ownership of, and all rights and interest in, the following three approved NADAs to Ridley U.S. Holdings, Inc., 424 North Riverfront Dr., P.O. Box 8500, Mankato, MN 56002-8500: Application Number
21 CFR Section
Trade NameNADA 033-733
520.1840
Sweetlix Bloat Guard Block( print page 62811)NADA 109-471
520.1448a
Cattle Block MNADA 136-214
520.1846
Enproal Bloat Blox
 Accordingly, the agency is amending the regulations in 21 CFR 520.1448a, 520.1840, and 520.1846 to reflect the transfer of ownership. Following these changes of sponsorship, Sweetlix LLC is no longer the sponsor of an approved application.  In addition, Ridley U.S. Holdings, Inc., is not currently listed in the animal drug regulations as a sponsor of an approved application.  Accordingly, § 510.600(c) is being amended to remove the entries for Sweetlix LLC and to add entries for Ridley U.S. Holdings, Inc. This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.”  Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808. List of Subjects 21 CFR Part 510 Administrative practice and procedure
Animal drugs
Labeling
Reporting and recordkeeping requirements 21 CFR Part 520 Animal drugs
 Therefore, under the Federal Food, Drug and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 and 520 are amended as follows: PART 510—NEW ANIMAL DRUGS
 1. The authority citation for 21 CFR parts 510 continues to read as follows: Authority:
                        21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e. 2. Section 510.600 is amended in the table in paragraph (c)(1) by removing the entry for “Sweetlix LLC” and by alphabetically adding an entry for “Ridley U.S. Holdings, Inc.” and in the table in paragraph (c)(2) by removing the entry for “036904” and by adding an entry for “067949” to read as follows: § 510.600
 
 (c)  *     *     * (1)  *     *     * Firm name and address
Drug labeler code*    *    *    *    *Ridley U.S. Holdings, Inc., 424 North Riverfront Dr., P.O. Box 8500, Mankato, MN 56002-8500
067949*    *    *    *    *
 (2)       *       *       * Drug labeler code
Firm name and address*    *    *    *    *067949
Ridley U.S. Holdings, Inc., 424 N. Riverfront Dr., P.O. Box 8500, Mankato, MN 56002-8500*    *    *    *    *
 PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS
 3.The authority citation for 21 CFR part 520 continues to read as follows: Authority:
                        21 U.S.C. 360b. § 520.1448a
 4.Section 520.1448a is amended in paragraph (a)(2) by removing “036904” and by adding in its place “No. 067949.” § 520.1840
 5.Section 520.1840 is amended in paragraph (b)(3) by removing “036904” and by adding in its place “067949.” § 520.1846
 6.Section 520.1846 is amended in paragraph (b) by removing “050112” and by adding in its place “067949.” Dated: October 20, 2004. Steven D. Vaughn, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.


[FR Doc. 04-24112 Filed 10-27-04; 8:45 am] BILLING CODE 4160-01-S